标题
Novel approaches for vaccine development
作者
关键词
-
出版物
CELL
Volume 184, Issue 6, Pages 1589-1603
出版商
Elsevier BV
发表日期
2021-03-19
DOI
10.1016/j.cell.2021.02.030
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Responses to Viral Gene Therapy Vectors
- (2020) Jamie L. Shirley et al. MOLECULAR THERAPY
- Characterization of a Species E Adenovirus Vector as a Zika virus vaccine
- (2020) Brianna L. Bullard et al. Scientific Reports
- Integrating Biomaterials and Immunology to Improve Vaccines Against Infectious Diseases
- (2020) Lampouguin Yenkoidiok-Douti et al. ACS Biomaterials-Science & Engineering
- Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17–22)
- (2020) Kathryn E Stephenson et al. Lancet HIV
- Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection
- (2020) Amy S. Espeseth et al. npj Vaccines
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Noncanonical Functions of Antibodies
- (2020) Jordan D. Dimitrov et al. TRENDS IN IMMUNOLOGY
- Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
- (2020) Lynda Coughlan Frontiers in Immunology
- Controlling timing and location in vaccines
- (2020) Darrell J. Irvine et al. ADVANCED DRUG DELIVERY REVIEWS
- Shaping humoral immunity to vaccines through antigen-displaying nanoparticles
- (2020) Darrell J Irvine et al. CURRENT OPINION IN IMMUNOLOGY
- Immune Sensing Mechanisms that Discriminate Self from Altered Self and Foreign Nucleic Acids
- (2020) Eva Bartok et al. IMMUNITY
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
- (2020) Milagritos D Tapia et al. LANCET INFECTIOUS DISEASES
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
- (2020) Neeltje van Doremalen et al. NATURE
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of mRNA chemistry and manufacturing process on innate immune activation
- (2020) Jennifer Nelson et al. Science Advances
- COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
- (2020) Young Hun Chung et al. ACS Nano
- Production, Processing, and Characterization of synthetic AAV Gene Therapy Vectors
- (2020) Jihad El Andari et al. Biotechnology Journal
- Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo
- (2020) Yu Kato et al. IMMUNITY
- Safety and Immunogenicity of Heterologous and Homologous Two Dose Regimens of Ad26- and MVA-Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study
- (2020) Neil Goldstein et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
- (2020) Denis Y Logunov et al. LANCET
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology
- (2020) Luis Apolonia Viruses-Basel
- Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda
- (2020) Jonathan Kitonsa et al. Global Health Action
- Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free world
- (2020) Rose Gana Fomban Leke et al. Lancet Global Health
- Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study
- (2020) Lindsey R Baden et al. Lancet HIV
- Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal
- (2020) Fernanda M. P. Rodrigues et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineering Immune Tolerance with Biomaterials
- (2019) Joshua M. Gammon et al. Advanced Healthcare Materials
- A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection
- (2019) Felicity Hartnell et al. Frontiers in Immunology
- Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactions
- (2019) Alexander T. Baker et al. Nature Communications
- Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
- (2019) Jessica Marcandalli et al. CELL
- Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance
- (2019) Kimberly M. Cirelli et al. CELL
- A review of 65 years of human adenovirus seroprevalence
- (2019) Franck J. D. Mennechet et al. Expert Review of Vaccines
- mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
- (2019) Robert A. Feldman et al. VACCINE
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
- (2019) Kimberly J. Hassett et al. Molecular Therapy-Nucleic Acids
- Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine
- (2019) Kenta Matsuda et al. Science Immunology
- The global burden of HIV and prospects for control
- (2019) Abhishek Pandey et al. Lancet HIV
- Adenovirus Vector-Based Vaccines Confer Maternal-Fetal Protection against Zika Virus Challenge in Pregnant IFN-αβR−/− Mice
- (2019) Rafael A. Larocca et al. Cell Host & Microbe
- Recent updates on drug resistance in Mycobacterium tuberculosis
- (2019) R. Singh et al. JOURNAL OF APPLIED MICROBIOLOGY
- mRNA structure regulates protein expression through changes in functional half-life
- (2019) David M. Mauger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response
- (2019) Sergio Linares-Fernández et al. TRENDS IN MOLECULAR MEDICINE
- Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
- (2019) Philip J. M. Brouwer et al. Nature Communications
- Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses
- (2018) Naihan Chen et al. JOURNAL OF CONTROLLED RELEASE
- Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy
- (2018) Rui Kuai et al. JOURNAL OF CONTROLLED RELEASE
- Immunogenicity and Cross-Reactivity of Rhesus Adenoviral Vectors
- (2018) M. Justin Iampietro et al. JOURNAL OF VIROLOGY
- Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors
- (2018) Peter Abbink et al. JOURNAL OF VIROLOGY
- Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
- (2018) Dan H Barouch et al. LANCET
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity
- (2018) Shinu John et al. VACCINE
- Biodegradable Polymeric Nanoparticles for Therapeutic Cancer Treatments
- (2018) Johan Karlsson et al. Annual Review of Chemical and Biomolecular Engineering
- Biomaterial-assisted targeted modulation of immune cells in cancer treatment
- (2018) Hua Wang et al. NATURE MATERIALS
- Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening
- (2018) Alexandra G. Orlandini von Niessen et al. MOLECULAR THERAPY
- Overcoming challenges in treating autoimmuntity: Development of tolerogenic immune-modifying nanoparticles
- (2018) Ryan M Pearson et al. Nanomedicine-Nanotechnology Biology and Medicine
- First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
- (2018) Alfred B. Tiono et al. PLoS One
- RNA sensors of the innate immune system and their detection of pathogens
- (2017) Nanhua Chen et al. IUBMB LIFE
- Rhesus Macaque Myeloid-Derived Suppressor Cells Demonstrate T Cell Inhibitory Functions and Are Transiently Increased after Vaccination
- (2017) Ang Lin et al. JOURNAL OF IMMUNOLOGY
- Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques
- (2017) Frank Liang et al. MOLECULAR THERAPY
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models
- (2017) Chao Shan et al. NATURE MEDICINE
- Functional 5′ UTR mRNA structures in eukaryotic translation regulation and how to find them
- (2017) Kathrin Leppek et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Simply put: Vaccination saves lives
- (2017) Walter A. Orenstein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens
- (2017) Giulietta Maruggi et al. VACCINE
- Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells
- (2017) Gustaf Lindgren et al. Frontiers in Immunology
- Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
- (2017) Johannes Lutz et al. npj Vaccines
- Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity
- (2016) Laura Northrup et al. ADVANCED DRUG DELIVERY REVIEWS
- Vaccine technologies: From whole organisms to rationally designed protein assemblies
- (2016) Christopher P. Karch et al. BIOCHEMICAL PHARMACOLOGY
- New concepts in HIV-1 vaccine development
- (2016) Kathryn E Stephenson et al. CURRENT OPINION IN IMMUNOLOGY
- Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011–20
- (2016) Sachiko Ozawa et al. HEALTH AFFAIRS
- Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA
- (2016) Zhikuan Zhang et al. IMMUNITY
- Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
- (2016) P. Abbink et al. SCIENCE
- Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON ® -TB Gold (+) Kenyan adults without evidence of tuberculosis
- (2016) Douglas S. Walsh et al. VACCINE
- Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens
- (2016) Yuchen Fan et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Viral vectors as vaccine carriers
- (2016) Hildegund CJ Ertl Current Opinion in Virology
- Taxonomy proposal for Old World monkey adenoviruses: characterisation of several non-human, non-ape primate adenovirus lineages
- (2015) Laura Pantó et al. ARCHIVES OF VIROLOGY
- In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
- (2015) Geoffrey M Lynn et al. NATURE BIOTECHNOLOGY
- M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protection
- (2015) Wenqian Tao et al. VACCINE
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Novel vaccine vectors for HIV-1
- (2014) Dan H. Barouch et al. NATURE REVIEWS MICROBIOLOGY
- Safety and Tolerability of Conserved Region Vaccines Vectored by Plasmid DNA, Simian Adenovirus and Modified Vaccinia Virus Ankara Administered to Human Immunodeficiency Virus Type 1-Uninfected Adults in a Randomized, Single-Blind Phase I Trial
- (2014) Emma-Jo Hayton et al. PLoS One
- Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
- (2014) Petr O. Ilyinskii et al. VACCINE
- Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses in Vitro and in Vivo
- (2013) Kenichi Niikura et al. ACS Nano
- Differential functional effects of biomaterials on dendritic cell maturation
- (2012) Jaehyung Park et al. Acta Biomaterialia
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
- (2012) Muthusamy Jayaraman et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Prevention of Maternal and Congenital Cytomegalovirus Infection
- (2012) JULIE JOHNSON et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines
- (2012) Charlotte Pollard et al. MOLECULAR THERAPY
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
- (2011) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Programming the magnitude and persistence of antibody responses with innate immunity
- (2011) Sudhir Pai Kasturi et al. NATURE
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
- (2011) Dan H. Barouch et al. VACCINE
- Innate immune sensing of DNA viruses
- (2011) Vijay A.K. Rathinam et al. VIROLOGY
- Adenovirus-Based Vaccines: Comparison of Vectors from Three Species ofAdenoviridae
- (2010) H. Chen et al. JOURNAL OF VIROLOGY
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
- (2010) Akin Akinc et al. MOLECULAR THERAPY
- Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
- (2010) Dan H Barouch et al. NATURE MEDICINE
- Nonviral Gene Delivery: Principle, Limitations, and Recent Progress
- (2009) Mohammed S. Al-Dosari et al. AAPS Journal
- The influence of innate and pre-existing immunity on adenovirus therapy
- (2009) Anne K. Zaiss et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
- (2009) Fiona A. Sharp et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
- (2009) Stacey L. Demento et al. VACCINE
- Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers
- (2009) David I. Bernstein et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search